首页> 美国卫生研究院文献>other >Targeting CD47 as a cancer therapeutic strategy – the cutaneous T cell lymphoma experience

【2h】

Targeting CD47 as a cancer therapeutic strategy – the cutaneous T cell lymphoma experience

机译：靶向CD47作为癌症治疗策略–皮肤T细胞淋巴瘤的经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose of reviewTo describe the relevance of CD47 in the tumor microenvironment and summarize data on anti-CD47 therapies, including its role in cutaneous T-cell lymphoma (CTCL).

机译：审查目的描述CD47在肿瘤微环境中的相关性，并概述抗CD47治疗的数据，包括其在皮肤T细胞淋巴瘤（CTCL）中的作用。

著录项

期刊名称 other
作者
Alecia S Folkes; Mingye Feng; Jasmine M Zain; Farah Abdulla; Steven T Rosen; Christiane Querfeld;
展开▼
作者单位

展开▼
年(卷),期 -1(30),5
年度 -1
页码 332–337
总页数 11
原文格式 PDF
正文语种
中图分类
关键词
cutaneous T-cell lymphoma innate immune checkpoint inhibitor anti-CD47 human SIRPα;

机译：皮肤T细胞淋巴瘤;先天免疫检查点抑制剂;抗CD47;人类SIRPα;

相似文献

外文文献
中文文献
专利

1. Targeting CD47 as a cancer therapeutic strategy: the cutaneous T-cell lymphoma experience [J] . Folkes Alecia S., Feng Mingye, Zain Jasmine M., Current Opinion in Oncology . 2018,第5期

机译：靶向CD47作为癌症治疗策略：皮肤T细胞淋巴瘤经验
2. Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma [J] . The Journal of investigative dermatology. . 2020,第5期

机译：用双抑制剂靶向PI3K / mTOR信号传导作为皮肤T细胞淋巴瘤的治疗策略
3. Targeting the vitamin B6 pathway as a novel therapeutic strategy for cutaneous T-cell lymphoma [J] . Chen C., Bayan C. Y., Lopez A., The Journal of investigative dermatology. . 2018,第5a19期

机译：靶向维生素B6途径作为皮肤T细胞淋巴瘤的新疗效策略
4. Combination Targeting of Immunoliposomal Therapeutics in a Murine Model of B-cell Lymphoma [C] . Annual meeting exposition of the Controlled Release Society . 2009

机译：B细胞淋巴瘤鼠模型中免疫脂质瘤治疗剂的组合靶向
5. Development of Novel Therapeutic Strategies for Targeting Metastatic Cancer Cells and Overcoming Cancer Stem Cell Chemoresistance [D] . Alford, Vincent M. 2017

机译：针对转移性癌细胞和克服癌症干细胞化学耐药性的新型治疗策略的发展
6. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy [O] . Christian M. Schürch, Matthias A. Roelli, Stefan Forster, -1

机译：在变性甲状腺癌中靶向CD47可增强巨噬细胞的肿瘤吞噬能力是一种有前途的治疗策略
7. Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma [O] . Antonella Bresin, Cristina Cristofoletti, Elisabetta Caprini, 2020

机译：用双抑制剂靶向PI3K / mTOR信号传导作为皮肤T细胞淋巴瘤的治疗策略
8. Targeting Midbodies in Ovarian Cancer Stem Cells as a Therapeutic Strategy. [R] . Doxsey, S. 2014

机译：针对卵巢癌干细胞中的中位体作为治疗策略。

Targeting CD47 as a cancer therapeutic strategy – the cutaneous T cell lymphoma experience

摘要

著录项

相似文献

相关主题

期刊订阅